Name: Champions Oncology, Inc. (CSBR) Financial Statements
Creator: FinSpry

Champions Oncology Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Champions Oncology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2025	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018
Revenue & Gross Profit
Revenue	56.94	50.16	53.87	49.11	41.04	32.12	27.07	20.24
Cost of Revenue	30.03	29.40	29.53	23.63	21.45	17.00	14.27	10.55
Gross Profit	26.92	20.75	24.34	25.48	19.59	15.12	12.80	9.69
Operating Expenses
Research & Development	6.83	9.54	11.55	9.37	7.20	5.85	4.80	4.40
Selling, General & Administrative	15.24	18.13	17.24	15.50	12.03	10.86	7.73	6.64
Operating Expenses	22.07	27.68	28.79	24.87	40.67	34.04	12.53	11.04
Operating Income	4.85	-6.92	-4.45	0.61	0.37	-1.92	0.27	-1.35
Other Income/Expense
Interest Income	0.09	0.09	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.03	-0.03	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	-0.22	0.39	-0.82	-0.02	-0.07	0.04	-0.04	-0.09
Income
Income Before Tax	4.63	-7.31	-5.27	0.58	0.44	-1.96	0.23	-1.44
Income Tax Expense	-0.08	-0.03	0.07	0.04	0.08	0.13	0.10	0.03
Net Income	4.70	-7.28	-5.34	0.55	0.36	-2.09	0.13	-1.48
Net Income - Continuous Operations	4.70	-7.28	-5.34	0.55	0.00	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	6.29	-5.05	-2.20	2.23	1.55	-0.76	0.88	-0.99
EBIT	4.85	-6.92	-4.45	0.61	0.37	-1.59	0.27	-1.35
Depreciation & Amortization	1.64	1.87	2.25	1.63	0.93	0.83	0.00	0.00
Earnings Per Share
Basic EPS	-	-1.00	-	-	-	-	-	-
Diluted EPS	-	-1.00	-	-	-	-	-	-
Basic Shares Outstanding	13.66	13.55	13.54	13.20	13.14	11.84	11.34	10.99
Diluted Shares Outstanding	14.27	13.55	13.54	14.16	14.57	11.84	14.10	10.99